Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1-2
|
| pubmed:dateCreated |
1989-6-16
|
| pubmed:abstractText |
An X-ray crystal structure determination was performed on 2 beta,4 beta-cyclo-5 alpha- and rostane-3 alpha,17 beta-diol diacetate. The parent diol, but not its 3 beta-epimer, had been shown to be an effective inhibitor of a 3 beta-hydroxysteroid dehydrogenase.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0039-128X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
52
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
37-43
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading | |
| pubmed:articleTitle |
The crystal structure of 2 beta,4 beta-cyclo-5 alpha-androstane-3 alpha,17 beta-diol diacetate.
|
| pubmed:affiliation |
Faculty of Medicine, Memorial University of Newfoundland, Canada.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|